⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL7932755 | 0.87 | — | — | |
| SCHEMBL13773990 | 0.83 | — | — | |
| SCHEMBL28518709 | 0.77 | — | — | |
| SCHEMBL905391 | 0.72 | — | — | |
| SCHEMBL13605232 | 0.72 | — | — | |
| SCHEMBL5665816 | 0.72 | — | — | |
| SCHEMBL13963674 | 0.72 | — | — | |
| SCHEMBL13174898 | 0.72 | — | — | |
| SCHEMBL38272 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL59965 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117202674-A | Near-infrared quantum dot light-emitting device insensitive to thickness and preparation method thereof | 苏州大学 | 2023-12-08 | — | — | CN | disclosed |
| WO-2023114640-A1 | DEPOSITION OF METALS IN RECESSED FEATURES WITH THE USE OF HALOGEN-CONTAINING DEPOSITION INHIBITORS | LAM RESEARCH CORPORATION (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20210386865-A1 | METHOD FOR SELECTIVELY MANUFACTURING ANTIBODY-DRUG CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2021-12-16 | — | — | US | disclosed |
| WO-2020243135-A1 | FUSED HETEROCYCLIC DERIVATIVES | Janssen Sciences Ireland Unlimited Company (IE) | 2020-12-03 | — | — | WO | disclosed |
| EP-2643867-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO (JP) | 2019-10-30 | — | — | EP | disclosed |
| EP-1155014-B1 | NEW BENZIMIDAZOLE COMPOUNDS FOR USE AS ACTIVE THERAPEUTIC SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE COMPOUDNS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PHARMACIA AB (SE) | 2003-06-04 | — | — | EP | disclosed |
| US-6329383-B1 | THESE COMPOUNDS ARE USEFUL AS A HUMAN GROWTH HORMONE (HGH) MIMETIC, WHICH TRIGGER GH AGONIST EFFECTS IN ANIMALS AND ESPECIALLY AS AN ORALLY AVAILABLE HUMAN GROWTH HORMONE (HGH). | PHARMACIA AB (SE) | 2001-12-11 | — | — | US | disclosed |
| EP-1155014-A1 | NEW BENZIMIDAZOLE COMPOUNDS FOR USE AS ACTIVE THERAPEUTIC SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE COMPOUDNS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | Pharmacia AB (SE) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000043387-A1 | NEW BENZIMIDAZOLE COMPOUNDS FOR USE AS ACTIVE THERAPEUTIC SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE COMPOUDNS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PHARMACIA AB (SE) | 2000-07-27 | — | — | WO | disclosed |